Status:

RECRUITING

Thrombosis and Inflammation in Vessels Initiative (TIVI)

Lead Sponsor:

National Heart, Lung, and Blood Institute (NHLBI)

Conditions:

Cardiovascular Diseases

Vascular Diseases

Eligibility:

All Genders

5-100 years

Brief Summary

Background: Diseases related to the immune system, blood clots, and blood vessels can affect every part of the body. These diseases are now known to be interrelated: People who have strokes, blood cl...

Detailed Description

Study Description: Thrombotic vascular disorders remain the leading cause of morbidity and mortality in the United States. The proximate determinants of thrombosis, arterial, venous, and lymphatic va...

Eligibility Criteria

Inclusion

  • INCLUSION CRITERIA:
  • In order to be eligible to participate in this study, an individual must meet all of the following criteria:
  • Age \>= 5 years at the time of consent
  • Ability of subject or Legally Authorized Representative (LAR) to understand and the willingness to sign a written informed consent document
  • In addition, the following cohort-specific inclusion criteria apply:
  • Affected Subjects:
  • Known or possible thrombotic, immune, or vascular disorder after review of the subject s medical records and/or discussion of medical history
  • Relatives of Affected Subjects:
  • Being a relative of an affected subject
  • Unrelated Healthy Controls:
  • In good general health as evidenced by medical history
  • EXCLUSION CRITERIA:
  • An individual who meets any of the following criteria will be excluded from participation in this study:
  • Any condition that in the opinion of the Investigator would warrant exclusion
  • Unrelated Healthy Controls:
  • Unrelated healthy volunteers who decline to have blood drawn and/or tissue studies or who do not consent to have samples stored for future research
  • Cognitively impaired individuals

Exclusion

    Key Trial Info

    Start Date :

    November 22 2024

    Trial Type :

    OBSERVATIONAL

    Allocation :

    ESTIMATED

    End Date :

    January 30 2034

    Estimated Enrollment :

    1000 Patients enrolled

    Trial Details

    Trial ID

    NCT06552767

    Start Date

    November 22 2024

    End Date

    January 30 2034

    Last Update

    January 8 2026

    Active Locations (1)

    Enter a location and click search to find clinical trials sorted by distance.

    Page 1 of 1 (1 locations)

    1

    National Institutes of Health Clinical Center

    Bethesda, Maryland, United States, 20892